Image Protect, Inc. has detailed its strategic growth vision and long-term revenue objectives centered on its flagship product, the InterceptCS™ Cold Sore Prevention System. The device, launched under the company's wholly owned subsidiary Global Wellness Products, holds Class II Medical Device approval from Health Canada for preventing cold sores, representing a significant entry into the wellness technology sector. The company is targeting a substantial market opportunity, with the cold sore market estimated at $1.2 billion annually in the United States, $150 million in Canada, and over $3.5 billion globally.
The company's business model focuses on device sales and recurring purchases of thermal activators, with management estimating each user could generate approximately $200 annually. With a long-term revenue goal of up to $100 million annually within five years, Image Protect is implementing a multi-channel sales strategy to capitalize on market demand. This includes direct-to-consumer ecommerce through platforms like Amazon, Walmart.com, and eBay, targeting key international markets including the United Kingdom, Australia, and the European Union.
To support brand awareness and customer acquisition, Global Wellness Products is deploying a comprehensive marketing strategy encompassing social media campaigns, paid advertising, search engine marketing, and influencer outreach. CEO Frank Casella emphasized the product's unique market position, noting its focus on prevention rather than symptom treatment, and highlighted ongoing product development initiatives designed to enhance consumer value and profitability. The company's approach leverages regulatory approvals and a robust ecommerce infrastructure to build InterceptCS™ into a globally recognized brand in personal wellness.
While expressing optimism about its growth trajectory, the company cautions that forward-looking statements are subject to risks and uncertainties, and actual results may vary. The strategic update underscores Image Protect's commitment to transforming its cold sore prevention technology into a significant revenue driver by addressing a widespread health concern through innovative wellness solutions and aggressive market penetration strategies across multiple sales channels.
